Analyst consensus rating
Precigen Analyst Rating: none
PGEN is rated none by 2 analysts with a $14.50 target. As of 2026-09-01.
Direct answer
Precigen's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.50.
Forecast evidence checked September 1, 2026.
Get free Precigen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.86
- Average price target
- $14.50
- High price target
- $18.00
- Low price target
- $11.00
- Low target gap
- +60.3%
- Target upside
- +111.4%
- High target gap
- +162.4%
- Target range width
- 102%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Precigen?
Precigen has a verified none consensus. The same dataset has an average price target of $14.50.
How far are Precigen's low and high targets from the recorded price?
The low target implies +60.3%, while the high target implies +162.4%.
How many analysts are included in Precigen's consensus?
The verified consensus includes 2 analysts.
How is Precigen's target upside or downside calculated?
The average target of $14.50 is divided by the recorded price of $6.86, then one is subtracted to produce +111.4%. This does not guarantee a future return.
When was Precigen's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.